HIGHLIGHTS
- who: Hu Fang from the School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China have published the paper: Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies, in the Journal: (JOURNAL)
- what: The authors show that these cancers harbour driver mutations that are accessible by GCV-associated mutagenesis, implicating DNA damage from GCV as a causative factor in initiating the disease. This study provides further evidence that GCV treatment influences cancer development in diverse organs.
- how: For signature analysis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.